Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-07-20
    E.g., 2018-07-20

Articles

12212 items
12:11 AM, Jun 25, 2018  |  BC Extra | Financial News

Sofinnova Partners, 5AM lead £28 million NodThera series A

Inflammation company NodThera Ltd. (Cambridge, U.K.) raised £28 million ($37 million) in a tranched series A led by Sofinnova Partners and 5AM Ventures. Epidarex Capital, which founded NodThera in 2016, and F-Prime Capital Partners also...
2:39 PM, Jun 23, 2018  |  BC Extra | Financial News

Latest batch of IPO filings: Rubius, Constellation, Replimune, Allakos

As a busy week for IPO pricings came to a close, several more companies filed for NASDAQ listings late Friday, further stocking an IPO pipeline of companies likely to seek liquidity during a tight calendar...
3:11 PM, Jun 22, 2018  |  BC Extra | Financial News

Crinetics proposes $86.3M IPO

Endocrine disease company Crinetics Pharmaceuticals Inc. (San Diego, Calif.) proposed to raise up to $86.3 million in an IPO on NASDAQ underwritten by J.P. Morgan, Leerink and Piper Jaffray. In March, Crinetics raised a $63.5 million...
7:56 PM, Jun 21, 2018  |  BC Extra | Financial News

First-day bump for Autolus after pricing $150M IPO

Autolus Therapeutics plc (NASDAQ:AUTL) climbed $8 (47%) to $25 its first day of trading Friday after it raised $150 million via the sale of 8.8 million ADSs at $17 in an upsized IPO. Underwriters are...
7:14 AM, Jun 21, 2018  |  BC Extra | Financial News

Rhythm raises $151.4M in follow-on

Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) raised $151.4 million through the sale of 5.7 million shares at $26.42 in a follow-on underwritten by Morgan Stanley, BofA Merrill Lynch, Cowen and Needham. The price is an 8% discount...
9:46 PM, Jun 20, 2018  |  BC Extra | Financial News

Four companies in IPO quintet post first-day gains

Four of the five biopharmas that priced IPOs late Wednesday posted gains on Thursday. Cell therapy company Avrobio Inc. (NASDAQ:AVRO) had the biggest first-day bump, climbing $12.20 (64%) to $31.20, while three others posted double-digit...
1:13 PM, Jun 20, 2018  |  BC Extra | Financial News

ObsEva raises $73M on heels of linzagolix data

ObsEva S.A. (NASDAQ:OBSV) raised $73.1 million through the sale of 4.8 million shares at $15.39 in a follow-on underwritten by J.P. Morgan, Credit Suisse Securities (USA), Jefferies, Wedbush Securities and H.C. Wainwright. The price is...
11:45 AM, Jun 20, 2018  |  BC Extra | Financial News

Galmed raises $75M follow-on

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) raised $75 million through the sale of 5 million shares at $15 in a follow-on underwritten by Stifel, SunTrust Robinson Humphrey, Cantor Fitzgerald, Raymond James, Roth Capital Partners, Maxim Group and...
7:24 AM, Jun 20, 2018  |  BC Extra | Financial News

Aminex raises $10M, starts Phase I cancer trial

Aminex Therapeutics Inc. (Seattle, Wash.) raised $10 million in an untranched series B round. The company declined to name its investors. The company said Wednesday that it dosed the first patient in a Phase I trial...
7:15 AM, Jun 20, 2018  |  BC Extra | Financial News

Eidos gets first-day bump after pricing IPO at top of range

Eidos Therapeutics Inc. (NASDAQ:EIDX) added $6.12 (36%) to $23.12 Wednesday after raising $106.3 million through the sale of 6.3 million shares at $17 in an IPO underwritten by J.P. Morgan, BofA Merrill Lynch and Barclays....

Pages